Janus Henderson Group PLC 4 D Molecular Therapeutics, Inc. Transaction History

Janus Henderson Group PLC

  • $194 Billion
  • Q2 2025

A detailed history of Janus Henderson Group PLC transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 1,754,410 shares of FDMT stock, worth $10.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,754,410
Previous 1,891,935 7.27%
Holding current value
$10.8 Million
Previous $6.11 Million 6.51%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$2.51 - $4.79 $345,187 - $658,744
-137,525 Reduced 7.27%
1,754,410 $6.51 Million
Q1 2025

May 15, 2025
SELL
$3.23 - $6.6 $1.16 Million - $2.38 Million
-360,305 Reduced 16.0%
1,891,935 $6.11 Million
Q4 2024

Feb 14, 2025
SELL
$5.3 - $10.41 $4.69 Million - $9.21 Million
-884,847 Reduced 28.21%
2,252,240 $12.5 Million
Q3 2024

Nov 14, 2024
SELL
$10.81 - $27.22 $645,086 - $1.62 Million
-59,675 Reduced 1.87%
3,137,087 $33.9 Million
Q2 2024

Aug 14, 2024
SELL
$20.93 - $30.01 $14,274 - $20,466
-682 Reduced 0.02%
3,196,762 $67.1 Million
Q1 2024

May 15, 2024
BUY
$17.03 - $35.87 $1.77 Million - $3.74 Million
104,148 Added 3.37%
3,197,444 $102 Million
Q4 2023

Feb 14, 2024
BUY
$9.76 - $21.25 $3.39 Million - $7.37 Million
346,961 Added 12.63%
3,093,296 $62.7 Million
Q3 2023

Nov 14, 2023
SELL
$12.64 - $19.76 $1.17 Million - $1.83 Million
-92,547 Reduced 3.26%
2,746,335 $35 Million
Q2 2023

Aug 14, 2023
BUY
$15.16 - $23.26 $14.6 Million - $22.4 Million
961,457 Added 51.21%
2,838,882 $51.3 Million
Q1 2023

May 15, 2023
BUY
$15.45 - $23.19 $6.35 Million - $9.53 Million
411,158 Added 28.04%
1,877,425 $32.3 Million
Q4 2022

Feb 14, 2023
BUY
$6.85 - $25.46 $1 Million - $3.73 Million
146,536 Added 11.1%
1,466,267 $32.6 Million
Q3 2022

Nov 14, 2022
SELL
$6.96 - $11.48 $106,606 - $175,839
-15,317 Reduced 1.15%
1,319,731 $10.6 Million
Q2 2022

Aug 15, 2022
SELL
$5.68 - $15.99 $1.88 Million - $5.28 Million
-330,363 Reduced 19.84%
1,335,048 $9.32 Million
Q1 2022

May 16, 2022
BUY
$13.16 - $22.64 $230,142 - $395,928
17,488 Added 1.06%
1,665,411 $25.2 Million
Q4 2021

Feb 14, 2022
BUY
$19.56 - $32.94 $2.48 Million - $4.18 Million
126,820 Added 8.34%
1,647,923 $36.2 Million
Q3 2021

Nov 16, 2021
SELL
$22.73 - $36.04 $423,300 - $671,172
-18,623 Reduced 1.21%
1,521,103 $41 Million
Q2 2021

Aug 16, 2021
BUY
$22.2 - $42.29 $6.93 Million - $13.2 Million
312,329 Added 25.45%
1,539,726 $37.1 Million
Q1 2021

May 17, 2021
BUY
$35.94 - $52.67 $7.39 Million - $10.8 Million
205,486 Added 20.11%
1,227,397 $50.7 Million
Q4 2020

Feb 16, 2021
BUY
$38.43 - $47.36 $39.3 Million - $48.4 Million
1,021,911 New
1,021,911 $39.9 Million

Others Institutions Holding FDMT

# of Institutions
124
Shares Held
41.2M
Call Options Held
19K
Put Options Held
38.3K
View Full List

About 4D Molecular Therapeutics, Inc.

FDMT Quotes by TradingView
  • Ticker FDMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,382,400
  • Market Cap $199M
  • Description
  • 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...
More about FDMT
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email